Back to results
US 2011/0195093 A1Published application
Tissue Targeted Antigenic Activation of the Immune Response to Treat Cancers
AssigneeQu Biologics Inc.
InventorHarold David Gunn
Life of this patent
Estimating the term…
Abstract
The invention provides in part methods of treating cancers of a specific organ or tissue by administering a composition that is antigenically specific for one or more microbes that are pathogenic in the specific organ or tissue in which the cancer is situated.
Claims21
1-97. (canceled)
A method for treating a human patient for a skin cancer, the method comprising:
- administering to the patient a medicament comprising an effective amount of an antigenic composition comprising antigenic determinants of whole killed cells of only one microbial pathogen, wherein the microbial pathogen is Staphylococcus aureus.
A method for selecting an immunogenic composition and treating a human patient, comprising:
- diagnosing the patient as having a skin cancer;
- selecting an antigenic composition comprising antigenic determinants of whole killed cells of only one microbial pathogen, wherein the microbial pathogen is Staphylococcus aureus;
- and,
- administering the antigenic composition to the patient to elicit an immune reaction to treat the cancer.
1 more element
Dependencies are inferred from the claim text.